Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2016 Publisher: Sun Pharmaceutical Industries Europe B.V., Polarisavenue 87, 2132 JH Hoofddorp, The Netherlands
Vecuronium SUN 10 mg powder for solution for injection/infusion.
| Pharmaceutical Form |
|---|
|
Powder for solution for injection/infusion. White to off-white lyophilised powder. |
Each vial contains vecuronium as 10 mg vecuronium bromide.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Vecuronium |
Vecuronium is a non-depolarising neuromuscular blocking agent. Vecuronium blocks the transmission process between the motor nerve-ending and striated muscle by binding competitively with acetylcholine to the nicotinic receptors located in the motor end-plate region of striated muscle. |
| List of Excipients |
|---|
|
Citric acid anhydrous |
Vecuronium SUN 10 mg powder for solution for injection/infusion is filled in 10 ml colorless tubular glass vial with grey bromobutyl rubber stopper sealed with red flip off aluminium seal.
Vecuronium SUN 10 mg powder for solution for injection/infusion is supplied in packs containing 1, 4, 10 and 20 vials.
Not all pack sizes may be marketed.
Sun Pharmaceutical Industries Europe B.V., Polarisavenue 87, 2132 JH Hoofddorp, The Netherlands
PL 31750/0091
30/09/2016
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
